These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9113444

  • 1. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients.
    McMillan RW, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, McDonald JC.
    Clin Transplant; 1997 Apr; 11(2):98-103. PubMed ID: 9113444
    [Abstract] [Full Text] [Related]

  • 2. Soluble HLA class II concentrations in normal individuals and transplant recipients. Comparison with soluble HLA class I concentrations.
    McDonald JC, Adamashvili I, Hayes JM, Aultman DF, Rhynes VK, Gelder FB.
    Transplantation; 1994 Dec 15; 58(11):1268-72. PubMed ID: 7992373
    [Abstract] [Full Text] [Related]

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Dec 15; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 4. Donor human leukocyte antigens in the circulation of liver allograft recipients.
    Chauhan B, Mathew JM, Shenoy S, Flye MW, Howard T, Mohanakumar T.
    Clin Transplant; 1995 Feb 15; 9(1):14-9. PubMed ID: 7742577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S.
    Liver Transpl; 2007 Oct 15; 13(10):1405-13. PubMed ID: 17902126
    [Abstract] [Full Text] [Related]

  • 13. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 15; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 14. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
    DeVito-Haynes LD, Jankowska-Gan E, Heisey D, Jutte NH, Balk AH, Weimar W, Claas FH, Warner TF, Mentzer RM, Love RB, Burlingham WJ.
    J Heart Lung Transplant; 1996 Oct 15; 15(10):1012-26. PubMed ID: 8913919
    [Abstract] [Full Text] [Related]

  • 15. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH, Susskind B, Kerman D, Lam M, Gerolami K, Williams J, Kalish R, Campbell M, Katz S, Van Buren CT, Frazier H, Radovancevic B, Fife S, Kahan B.
    J Heart Lung Transplant; 1998 Aug 15; 17(8):789-94. PubMed ID: 9730428
    [Abstract] [Full Text] [Related]

  • 16. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, Rutgrink E, Ramsoebhag A, Hop A, Persijn G, Laufer G.
    Clin Transpl; 2003 Aug 15; ():89-100. PubMed ID: 15387100
    [Abstract] [Full Text] [Related]

  • 17. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 19. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V, Herrine S, Katopes C, Colombe B, Spain CV.
    Liver Transpl; 2006 Apr 15; 12(4):652-8. PubMed ID: 16555339
    [Abstract] [Full Text] [Related]

  • 20. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S, Valente U, Nocera A.
    Clin Transplant; 2007 Apr 15; 21(1):47-56. PubMed ID: 17302591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.